Intraoperative fluorescence imaging in thoracic surgery
- PMID: 30098293
- PMCID: PMC6146026
- DOI: 10.1002/jso.25149
Intraoperative fluorescence imaging in thoracic surgery
Abstract
Intraoperative fluorescence imaging (IFI) can improve real-time identification of cancer cells during an operation. Phase I clinical trials in thoracic surgery have demonstrated that IFI with second window indocyanine green (TumorGlow® ) can identify subcentimeter pulmonary nodules, anterior mediastinal masses, and mesothelioma, while the use of a folate receptor-targeted near-infrared agent, OTL38, can improve the specificity for diagnosing tumors with folate receptor expression. Here, we review the existing preclinical and clinical data on IFI in thoracic surgery.
Keywords: OTL38; indocyanine green (ICG); intraoperative fluorescence imaging (IFI); near-infrared (NIR) fluorescence imaging; thoracic surgery.
© 2018 Wiley Periodicals, Inc.
Figures
References
-
- Lohman RF, Ozturk CN, Ozturk C, et al. An Analysis of Current Techniques Used for Intraoperative Flap Evaluation. Ann Plast Surg. 2015;75(6):679–85. - PubMed
-
- Keller DS, Ishizawa T, Cohen R, et al. Indocyanine green fluorescence imaging in colorectal surgery: overview, applications, and future directions. Lancet Gastroenterol Hepatol. 2017;2(10):757–66. - PubMed
-
- Ishizawa T, Fukushima N, Shibahara J, et al. Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009;115(11):2491–504. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
